Department of Surgery, Open NBI Convergence Technology Research Laboratory, Severance Hospital, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
Yonsei University College of Medicine, Seoul, South Korea.
Eur J Endocrinol. 2020 Jul;183(1):83-93. doi: 10.1530/EJE-20-0131.
The characteristics of metastatic lymph nodes (MLNs) have been investigated as important predictors of recurrence and progression in papillary thyroid cancer (PTC). However, clinically applicable risk stratification systems are limited to the assessment of size and number of MLNs. This study investigated the predictive value of detailed characteristics of MLNs in combination with currently used risk stratification systems.
We retrospectively characterized 2811 MLNs from 9014 harvested LNs of 286 patients with N1 PTC according to the maximum diameter of MLN (MDLN), maximum diameter of metastatic focus (MDMF), ratio of both diameters (MDMFR), lymph node ratio (LNR, number of MLNs/number of total harvested LNs), presence of extranodal extension (ENE), desmoplastic reaction (DR), cystic component, and psammoma body.
Factors related to the size and number of MLNs were associated with increased risk of recurrence and progression. Extensive presence of ENE (>40%) and DR (≥50%) increased the risk of recurrence/progression. The combination of MDLN, LNR, ENE, and DR had the highest predictive value among MLN characteristics. Combination of these parameters with ATA risk stratification or 1-year response to therapy improved the predictive power for recurrence/progression from a Harrell's C-index of 0.781 to 0.936 and 0.867 to 0.960, respectively.
The combination of currently used risk stratification systems with detailed characterization of MLNs may improve the predictive accuracy for recurrence/progression in N1 PTC patients.
转移性淋巴结(MLN)的特征已被研究为甲状腺乳头状癌(PTC)复发和进展的重要预测因子。然而,临床适用的风险分层系统仅限于评估 MLN 的大小和数量。本研究探讨了 MLN 详细特征与目前使用的风险分层系统相结合的预测价值。
我们回顾性地描述了 286 例 N1 PTC 患者的 9014 个采集淋巴结中的 2811 个 MLN,根据 MLN 的最大直径(MDLN)、转移性焦点的最大直径(MDMF)、两个直径的比值(MDMFR)、淋巴结比(LNR,MLN 数量/总采集淋巴结数量)、有无外膜侵犯(ENE)、纤维反应(DR)、囊性成分和沙粒体体进行特征描述。
与 MLN 大小和数量相关的因素与复发和进展的风险增加有关。广泛存在的 ENE(>40%)和 DR(≥50%)增加了复发/进展的风险。在 MLN 特征中,MDLN、LNR、ENE 和 DR 的组合具有最高的预测价值。这些参数与 ATA 风险分层或 1 年治疗反应的组合可将复发/进展的预测能力从 Harrell's C 指数的 0.781 提高到 0.936 和 0.867 提高到 0.960。
目前使用的风险分层系统与 MLN 的详细特征相结合,可能会提高 N1 PTC 患者复发/进展的预测准确性。